Kevin M. Lally Partner

Save current page as PDF

Kevin has extensive experience handling complex, high-stakes federal criminal investigations, enforcement proceedings, and litigation. He served as a federal prosecutor in the U.S. Attorney’s Office for the Central District of California for nearly two decades, most recently as senior litigation counsel in the Major Frauds Section. As a partner in the firm’s nationally recognized Government Investigations & White Collar Litigation Department, Kevin’s strong trial and appellate record, demonstrated leadership, and keen understanding of the market provides a powerful advantage for clients.

During his 18-year tenure as an Assistant U.S. Attorney, including five years as Chief of the Organized Crime Drug Enforcement Task Force Section, Kevin led several of the highest-profile and heaviest-litigated cases brought by the Central District of California in the last two decades. He tried 15 cases, including four multi-month trials, and secured the conviction of every trial defendant. He successfully prosecuted five RICO cases and supervised more than a dozen more, many of which involved untested applications of the statute to novel fact patterns. Kevin was named Prosecutor of the Year by the Los Angeles County Bar Association after prevailing in the three-month RICO trial of celebrity private investigator Anthony Pellicano. He has argued 18 cases before the 9th U.S. Circuit Court of Appeals, including a sweeping victory in the consolidated Pellicano appeals.

Kevin supervised the successful prosecution of the nation’s first drug-based Hawala money laundering trial, which the DOJ recognized as the 2018 Transnational Money Laundering Case of the Year, as well as the indictment and guilty plea in the district’s first cryptocurrency money laundering case. Finally, Kevin led the operation of a DOJ award-winning and nationally-modeled opioid enforcement program that utilizes advanced data analytics to target physicians, pharmacies, and medical clinics engaged in illicit drug diversion and to secure convictions on charges including health care fraud, tax fraud, wire fraud, money laundering, and acquiring DEA registrations and controlled substances through fraud.